FREQUENCY OF PLACENTAL ABRUPTION AMONG PREGNANT INDIVIDUALS AFFECTED BY HYPERTENSIVE DISORDERS

Main Article Content

Bibi Sajida
Sadaf Ijaz
Asma Mumtaz
Hani Baloch
Humaira Yousaf
Orji Faith Chidi
Marium Nausherwan

Keywords

Hypertensive disorders, pregnancy, placental abruption, and fetal health

Abstract

Placental abruption is a medical condition characterized by the premature separation of the placenta from the uterine wall before the baby is delivered. Placental abruption remains a prevalent condition in the field of obstetrics, and it continues to pose a mystery as well. Despite the progress made in obstetrics, there are currently no dependable tests or biomarkers available to anticipate and preemptively address the occurrence of placental abruption, which can still be a daunting challenge for the medical team. Placental abruption represents a significant obstetric complication, carrying substantial risks for both maternal and fetal well-being. This research endeavor aims to explore the occurrence rate of placental abruption among pregnant individuals affected by hypertensive disorders. Conditions like preeclampsia and gestational hypertension are recognized as factors that elevate the chances of experiencing placental abruption. Gaining an understanding of the prevalence of this complication in hypertensive pregnancies assumes critical importance for timely detection and effective intervention. We conducted an extensive examination of medical records and obstetric outcomes within a sizable cohort of expectant mothers afflicted by hypertensive disorders. Our study outcomes provide valuable insights into the frequency of placental abruption in this specific demographic, thereby emphasizing the imperative for enhanced monitoring and improved care strategies to mitigate associated risks.

Abstract 249 | Pdf Downloads 177

References

1. Kintiraki, E.; Papakatsika, S.; Kotronis, G.; Goulis, D.G.; Kotsis, V. Pregnancy-Induced Hypertension. Hormones 2015, 14, 211–223.
2. Wilkerson, R.G.; Ogunbodede, A.C. Hypertensive Disorders of Pregnancy. Emerg. Med. Clin. 2019, 37, 301–316.
3. Farkhodovna, K.M. Complications of Pregnancy and Childbirth in Obese Women. J. Healthc. LIFE-SCIENCE Res. 2023, 2, 12–16.
4. McNestry, C.; Killeen, S.L.; Crowley, R.K.; McAuliffe, F.M. Pregnancy Complications and Later Life Women’s Health. Acta Obstet. Gynecol. Scand. 2023, 102, 523–531.
5. Lundberg, F.E.; Gkekos, L.; Rodriguez‐Wallberg, K.A.; Fredriksson, I.; Johansson, A.L. V Risk of Obstetric and Perinatal Complications in Women Presenting with Breast Cancer during Pregnancy and the First Year Postpartum in Sweden 1973–2017: A Population‐based Matched Study. Acta Obstet. Gynecol. Scand. 2023.
6. Sajith, M.; Nimbargi, V.; Modi, A.; Sumariya, R.; Pawar, A. Incidence of Pregnancy Induced Hypertension and Prescription Pattern of Antihypertensive Drugs in Pregnancy. Int J Pharma Sci Res 2014, 23, 4.
7. Magee, L.A.; Smith, G.N.; Bloch, C.; Côté, A.-M.; Jain, V.; Nerenberg, K.; von Dadelszen, P.; Helewa, M.; Rey, E. Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management. J. Obstet. Gynaecol. Canada 2022, 44, 547–571.
8. Magee, L.A.; Pels, A.; Helewa, M.; Rey, E.; von Dadelszen, P. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. An Int. J. Women’s Cardiovasc. Heal. 2014, 4, 105–145.
9. Von Dadelszen, P.; Magee, L.A. Preventing Deaths Due to the Hypertensive Disorders of Pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 2016, 36, 83–102.
10. Organization, W.H. Essential Nutrition Actions: Improving Maternal, Newborn, Infant and Young Child Health and Nutrition. 2013.
11. Nakimuli, A.; Nakubulwa, S.; Kakaire, O.; Osinde, M.O.; Mbalinda, S.N.; Nabirye, R.C.; Kakande, N.; Kaye, D.K. Maternal near Misses from Two Referral Hospitals in Uganda: A Prospective Cohort Study on Incidence, Determinants and Prognostic Factors. BMC Pregnancy Childbirth 2016, 16, 1–10.
12. Hossain, N.; Shah, N.; Khan, N.; Lata, S.; Khan, N.H. Maternal and Perinatal Outcome of Hypertensive Disorders of Pregnancy at a Tertiary Care Hospital. J. Dow Univ. Heal. Sci. 2011, 5, 12–16.
13. Khattak, S.N.; Deeba, F.; Ayaz, A.; Khattak, M.I. Association of Maternal Hypertension with Placental Abruption. J. Ayub Med. Coll. Abbottabad 2012, 24, 103–105.
14. Garovic, V.D.; White, W.M.; Vaughan, L.; Saiki, M.; Parashuram, S.; Garcia-Valencia, O.; Weissgerber, T.L.; Milic, N.; Weaver, A.; Mielke, M.M. Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy. J. Am. Coll. Cardiol. 2020, 75, 2323– 2334.
15. Scantlebury, D.C.; Schwartz, G.L.; Acquah, L.A.; White, W.M.; Moser, M.; Garovic, V.D. The Treatment of Hypertension during Pregnancy: When Should Blood Pressure Medications Be Started? Curr. Cardiol. Rep. 2013, 15, 1–10.
16. Townsend, R.; O’Brien, P.; Khalil, A. Current Best Practice in the Management of Hypertensive Disorders in Pregnancy. Integr. Blood Press. Control 2016, 79–94.
17. Magee, L.A.; Helewa, M.; Moutquin, J.-M.; von Dadelszen, P.; Committee, H.G. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. J. Obstet. Gynaecol. Canada 2008, 30, S1-48.
18. Wu, P.; Green, M.; Myers, J.E. Hypertensive Disorders of Pregnancy. bmj 2023, 381.
19. Tierney, J.F.; Stewart, L.A. Investigating Patient Exclusion Bias in Meta-Analysis. Int. J. Epidemiol. 2005, 34, 79–87.
20. Li, J.; Ma, H.; Yang, H.; Yu, H.; Zhang, N. Cognitive Bias Modification for Adult’s Depression: A Systematic Review and Meta-Analysis. Front. Psychol. 2023, 13, 968638.
21. Peters, R.M. High Blood Pressure in Pregnancy. Nurs. Womens. Health 2008, 12, 410–422.
22. Moser, M.; Brown, C.M.; GAROVIC, V.D. Hypertension in Pregnancy: Is It Time for a New Approach to Treatment? J. Hypertens. 2012, 30, 1092.
23. Group, M.T.C. Do Women with Pre-Eclampsia, and Their Babies, Benefit from Magnesium Sulphate? The Magpie Trial: A Randomised Placebo-Controlled Trial. Lancet 2002, 359, 1877–1890.
24. Hegde, S. A Randomized Comparative Study Between Neonatal Outcomes of Eclamptic Mothers Treated with Low Dose Magnesium Sulphate and Standard Dose Regimen for Management of Eclampsia in Mc Gann District Teaching Hospital, Shivamogga 2018.
25. Li, B.; Yang, H. Comparison of Clinical Features and Pregnancy Outcomes in Early-and Late-Onset Preeclampsia with HELLP Syndrome: A 10-Year Retrospective Study from a Tertiary Hospital and Referral Center in China. BMC Pregnancy Childbirth 2022, 22, 186.
26. Sibai, B.M.; Committee, P.; Medicine, S. for M.-F. Evaluation and Management of Severe Preeclampsia before 34 Weeks’ Gestation. Am. J. Obstet. Gynecol. 2011, 205, 191–198.
27. Caldwell, K.L.; Makhmudov, A.; Ely, E.; Jones, R.L.; Wang, R.Y. Iodine Status of the US Population, National Health and Nutrition Examination Survey, 2005–2006 and 2007– 2008. Thyroid 2011, 21, 419–427.
28. Johnson, C.L.; Dohrmann, S.M.; Burt, V.L.; Mohadjer, L.K. National Health and Nutrition Examination Survey: Sample Design, 2011-2014; US Department of Health and Human Services, Centers for Disease Control and …, 2014;
29. Samadian, F.; Dalili, N.; Jamalian, A. Lifestyle Modifications to Prevent and Control Hypertension. Iran. J. Kidney Dis. 2016, 10.
30. Timsina, Y.P.; Pandey, P.; Mondal, I.H.; Dar, A.H. Non-Pharmacological Management of Hypertension: A Systematic Review. Food Chem. Adv. 2023, 3, 100406.
31. Simas, T.A.M.; Liao, X.; Garrison, A.; Sullivan, G.M.T.; Howard, A.E.; Hardy, J.R. Impact of Updated Institute of Medicine Guidelines on Prepregnancy Body Mass Index Categorization, Gestational Weight Gain Recommendations, and Needed Counseling. J. women’s Heal. 2011, 20, 837–844.